BFRIW
Biofrontera Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.02
−25.93%Aug 13, 2026, 12:51 UTC
Biofrontera Inc. reported its financial results for the second quarter of 2026, highlighting a 33% revenue growth.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
Aug 13, 2026, 12:51 UTC